In this article we will quickly re-cap the broker forecasts for Brooks Macdonald (LON:BRK). The Brooks Macdonald share price has risen by 6.29% over the past month and it’s currently trading at 1747.5. For investors considering whether...
|Type||Buy / Hold / Sell|
|Year End 30th Jun||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for BRK
The Brooks Macdonald (LON:BRK) share price has risen by 6.91% over the past month and it’s currently trading at 1625.7. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will c...
The Brooks Macdonald (LON:BRK) share price has risen by 5.03% over the past month and it’s currently trading at 1742.5. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will c...
The Brooks Macdonald (LON:BRK) share price has risen by 2.56% over the past month and it’s currently trading at 1603. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will con...
The Brooks Macdonald (LON:BRK) share price has risen by 22.4% over the past month and it’s currently trading at 1655. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will con...
Brooks Macdonald Group plc is primarily engaged in providing investment management services. The Company operates through two operating segments: UK Investment Management and International. The UK Investment Management segment offers a range of investment management services to private individuals, pension funds, institutions, charities and trusts, as well as wealth management services to individuals and families. The International segment is based in the Channel Islands and offers a similar range of investment management and financial planning services as the UK Investment Management segment. The Company has approximately 14 offices across the United Kingdom and the Channel Islands, including London, Cheltenham, East Anglia, Exeter, Hampshire, Leamington Spa, Leeds, Manchester, Tunbridge Wells, Scotland, Wales, Jersey and Guernsey and Isle of Man.
Latest News for BRK
Upcoming Events for BRK
Full Year 2022 Brooks Macdonald Group PLC Earnings Release
Brooks Macdonald Group PLC Annual Shareholders Meeting
As of Today at 19:03 UTC, shares in Brooks Macdonald are trading at 2,200.00p. This share price information is delayed by 15 minutes.
Shares in Brooks Macdonald last closed at 2,200.00p and the price had moved by -3.3% over the past 365 days. In terms of relative price strength the Brooks Macdonald share price has underperformed the FTSE All Share Index by -0.21% over the past year.
The overall consensus recommendation for Brooks Macdonald is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Brooks Macdonald dividend yield is 3% based on the trailing twelve month period.
Last year, Brooks Macdonald paid a total dividend of £0.66, and it currently has a trailing dividend yield of 3%. We do not have any data on when Brooks Macdonald is to next pay dividends.
We do not have data on when Brooks Macdonald is to next pay dividends. The historic dividend yield on Brooks Macdonald shares is currently 3%.
To buy shares in Brooks Macdonald you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 2,200.00p, shares in Brooks Macdonald had a market capitalisation of £356.19m.
Here are the trading details for Brooks Macdonald:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: BRK
Based on an overall assessment of its quality, value and momentum Brooks Macdonald is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Brooks Macdonald is 2,832.50p. That is 28.75% above the last closing price of 2,200.00p.
Analysts covering Brooks Macdonald currently have a consensus Earnings Per Share (EPS) forecast of £1.58 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Brooks Macdonald. Over the past six months, its share price has underperformed the FTSE All Share Index by -10.57%.
As of the last closing price of 2,200.00p, shares in Brooks Macdonald were trading -11.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Brooks Macdonald PE ratio based on its reported earnings over the past 12 months is 13.06. The shares last closed at 2,200.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Brooks Macdonald's management team is headed by:
- Alan Carruthers - NEC
- Andrew Shepherd - CEO
- Ben Thorpe - CFO
- Richard Hughes - CEX
- Lynsey Cross - COO
- Edward Park - CIN
- Priti Verma - CRO
- Robin Eggar - MDR
- Tom Emery - DHR
- Alick Mackay - OTH
- Robert Burgess - NID
- Dagmar Aspatria Kershaw - NID
- John Linwood - NID
- Richard Price - NID